International journal of antimicrobial agents · 2026
In vivo emergence of cross-resistance to ceftazidime/avibactam and cefiderocol through selection of KPC variants in Klebsiella pneumoniae clinical isolates.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Bianco Gabriele, Findlay Jacqueline, Comini Sara, Costa Cristina, Nordmann Patrice, Boattini Matteo
Аннотация
OBJECTIVES: To investigate the clinical and molecular drivers of in-vivo cross-resistance to ceftazidime/avibactam (CZA) and cefiderocol (FDC) in infections caused by KPC-producing Klebsiella pneumoniae (KPC-Kp).
MATERIAL AND METHODS: We conducted a retrospective case series of patients initially infected or colonized by CZA- and FDC-susceptible KPC-Kp who subsequently developed infections due to strains co-resistant to both agents. Whole-genome sequencing (WGS) and cloning of blaKPC alleles into E. coli were performed to elucidate resistance mechanisms.
RESULTS: Three patients developed bloodstream infections with KPC-Kp resistant to both CZA and FDC following CZA exposure. WGS identified blaKPC variants featuring substitutions within or adjacent to the Ω-loop: KPC-31 (D179Y), KPC-49 (R164S), and KPC-167 (D179Y with a DDKYSE 270-loop duplication). All resistant isolates belonged to ST512 and exhibited porin alterations (OmpK35 truncation and OmpK36 GD insertion). Cloning experiments demonstrated that these KPC variants markedly increased CZA MICs and modestly elevated FDC MICs, confirming their functional contribution to the resistance phenotype.
CONCLUSIONS: These findings demonstrate the in-vivo emergence of cross-resistance to CZA and FDC driven by stepwise selection of KPC Ω-loop and 270-loop variants combined with permeability defects.
MATERIAL AND METHODS: We conducted a retrospective case series of patients initially infected or colonized by CZA- and FDC-susceptible KPC-Kp who subsequently developed infections due to strains co-resistant to both agents. Whole-genome sequencing (WGS) and cloning of blaKPC alleles into E. coli were performed to elucidate resistance mechanisms.
RESULTS: Three patients developed bloodstream infections with KPC-Kp resistant to both CZA and FDC following CZA exposure. WGS identified blaKPC variants featuring substitutions within or adjacent to the Ω-loop: KPC-31 (D179Y), KPC-49 (R164S), and KPC-167 (D179Y with a DDKYSE 270-loop duplication). All resistant isolates belonged to ST512 and exhibited porin alterations (OmpK35 truncation and OmpK36 GD insertion). Cloning experiments demonstrated that these KPC variants markedly increased CZA MICs and modestly elevated FDC MICs, confirming their functional contribution to the resistance phenotype.
CONCLUSIONS: These findings demonstrate the in-vivo emergence of cross-resistance to CZA and FDC driven by stepwise selection of KPC Ω-loop and 270-loop variants combined with permeability defects.